Ray Dalio's IDXX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 7,404 shares of IDEXX Laboratories, Inc. (IDXX) worth $4.73 M, representing 0.02% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in IDXX, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2022, adding 35,770 shares. Largest reduction occurred in Q4 2023, reducing 57,969 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's IDEXX Laboratories (IDXX) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEXX Laboratories (IDXX) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2014 | +4,602 | New Buy | 4,602 | $60.63 |
| Q2 2014 | -4,602 | Sold Out | 4,602 | $0.00 |
| Q3 2014 | +14,226 | New Buy | 14,226 | $58.91 |
| Q4 2014 | -14,226 | Sold Out | 14,226 | $0.00 |
| Q2 2015 | +4,226 | New Buy | 4,226 | $64.13 |
| Q3 2015 | +3,600 | Add 85.19% | 7,826 | $74.24 |
| Q4 2015 | -7,826 | Sold Out | 7,826 | $0.00 |
| Q3 2017 | +1,743 | New Buy | 1,743 | $155.48 |
| Q4 2017 | -1,743 | Sold Out | 1,743 | $0.00 |
| Q1 2018 | +5,495 | New Buy | 5,495 | $191.45 |
| Q2 2018 | -2,994 | Reduce 54.49% | 2,501 | $217.91 |
| Q3 2018 | -2,501 | Sold Out | 2,501 | $0.00 |
| Q4 2018 | +8,348 | New Buy | 8,348 | $186.03 |
| Q1 2019 | -8,348 | Sold Out | 8,348 | $0.00 |
| Q3 2019 | +3,646 | New Buy | 3,646 | $271.80 |
| Q4 2019 | -3,646 | Sold Out | 3,646 | $0.00 |
| Q1 2020 | +2,702 | New Buy | 2,702 | $242.41 |
| Q2 2020 | -2,702 | Sold Out | 2,702 | $0.00 |
| Q3 2020 | +20,753 | New Buy | 20,753 | $393.10 |
| Q4 2020 | +21,984 | Add 105.93% | 42,737 | $499.87 |
| Q1 2021 | -1,027 | Reduce 2.40% | 41,710 | $489.31 |
| Q2 2021 | +28,974 | Add 69.47% | 70,684 | $631.54 |
| Q3 2021 | +17,821 | Add 25.21% | 88,505 | $621.90 |
| Q4 2021 | +15,166 | Add 17.14% | 103,671 | $658.46 |
| Q1 2022 | +35,770 | Add 34.50% | 139,441 | $547.06 |
| Q2 2022 | -2,240 | Reduce 1.61% | 137,201 | $350.73 |
| Q3 2022 | +6,972 | Add 5.08% | 144,173 | $325.80 |
| Q4 2022 | -23,409 | Reduce 16.24% | 120,764 | $407.96 |
| Q1 2023 | -17,392 | Reduce 14.40% | 103,372 | $500.08 |
| Q2 2023 | +4,363 | Add 4.22% | 107,735 | $502.23 |
| Q3 2023 | +9,096 | Add 8.44% | 116,831 | $437.27 |
| Q4 2023 | -57,969 | Reduce 49.62% | 58,862 | $555.05 |
| Q1 2024 | -24,337 | Reduce 41.35% | 34,525 | $539.93 |
| Q2 2024 | -2,099 | Reduce 6.08% | 32,426 | $487.20 |
| Q3 2024 | -19,677 | Reduce 60.68% | 12,749 | $505.22 |
| Q4 2024 | -3,888 | Reduce 30.50% | 8,861 | $413.44 |
| Q1 2025 | -5,427 | Reduce 61.25% | 3,434 | $419.95 |
| Q2 2025 | -809 | Reduce 23.56% | 2,625 | $536.34 |
| Q3 2025 | +4,779 | Add 182.06% | 7,404 | $638.89 |
Ray Dalio's IDEXX Laboratories Investment FAQs
Ray Dalio first purchased IDEXX Laboratories, Inc. (IDXX) in Q1 2014, acquiring 4,602 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held IDEXX Laboratories, Inc. (IDXX) for 47 quarters since Q1 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to IDEXX Laboratories, Inc. (IDXX) was in Q1 2022, adding 139,441 shares worth $76.28 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 7,404 shares of IDEXX Laboratories, Inc. (IDXX), valued at approximately $4.73 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, IDEXX Laboratories, Inc. (IDXX) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in IDEXX Laboratories, Inc. (IDXX) was 144,173 shares, as reported at the end of Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.